Drug Policy Research Center Quarterly Newsletter

DPRC Quarterly is an electronic newsletter highlighting RAND research on key public policy findings in substance use and drug policy research. The newsletter is free: to subscribe, enter your email in the subscription box to the right and click "Sign Up."

2023

  • African-American man's claspling hands with the elbows leaning on his knees, photo by Vladimir Vladimirov/Getty Images

    Psychedelic Treatment Barriers for Veterans

    DPRC Quarterly, Issue 32, highlights the rise in opioid deaths, non-profit models of cannabis regulation, ISSDP call for abstracts, and more.

    Nov 14, 2023

  • Three open bottles of prescription medication with pills spilling out, photo by sdominick/Getty Images

    Polydrug Deaths & Supply-Side Interventions

    DPRC Quarterly, Issue 31, highlights changing policies for psychedelics, treating co-occurring mental health and opioid use disorders, and more.

    Aug 17, 2023

  • Two photos of Martin Y. Iguchi, one superimposed over the other, image by Kekeli Sumah/RAND Corporation

    Memorializing Martin Y. Iguchi

    DPRC Quarterly, Issue 30, highlights ISSDP2023, behavioral health care delivery following COVID, and more.

    May 9, 2023

  • Closeup of six water drops surrounding a larger drop on a green leaf, photo by ThomasVogel/Getty Images

    The Opioid Ecosystem

    DPRC Quarterly, Issue 29, highlights digital equity strategies for treating opioid use disorder, 24/7 Sobriety effectiveness, and more.

    Mar 16, 2023

2022

2021

2020

  • Psilocybin mushrooms being placed into a pill box, photo by microgen/Getty Images

    Newsletter

    Being Mindful About Changing Psychedelic Policy

    DPRC Quarterly, Issue 20, highlights research on alcohol consumption during the pandemic, levels of substance use disorder stigma among police officers, a RAND prevention research project, and more.

    Nov 16, 2020

  • Industrial Hemp (Cannabis sativa) being grown in Queenstown, MD USA

    Newsletter

    COVID Relief and Cannabis Legalization

    DPRC Quarterly, Issue 19, highlights research on cannabis policy and COVID-19, the effectiveness of naloxone laws, integrated substance use and mental health treatment for veterans, and more.

    Aug 31, 2020

  • Scientist taking water samples, photo by Smederevac/Getty Images

    Newsletter

    Want to Know If a New Drug Crisis Is Growing? Check the Wastewater

    DPRC Quarterly, Issue 18, highlights research on wastewater testing, the fentanyl problem in the U.S., state policies related to substance use in pregnancy, alcohol misuse in women, and more.

    May 20, 2020

  • Interconnected blue lines on black background, photo by Design Cells/Getty Images

    Newsletter

    Launching RAND's New Initiative: Opioids Uncharted

    DPRC Quarterly, Issue 17, highlights research on teaching skills to reduce DUI recidivism, the fentanyl crisis, policies that punish pregnant women for substance use, and more.

    Mar 9, 2020

2019

  • Close up of a man holding cannabis products in a cannabis dispensary, photo by CasarsaGuru/Getty Images

    Newsletter

    Early Evidence of the Impact of Cannabis Legalization

    DPRC Quarterly, Issue 16, highlights research on cannabis legalization, tackling America's fentanyl problem, cognitive behavioral therapy for first-time DUI offenses, and more.

    Nov 8, 2019

  • Fentanyl molecule structure, image by serge01/Adobe Stock

    Newsletter

    The Future of Fentanyl and Other Synthetic Opioids

    DPRC Quarterly, Issue 15, highlights research on the size of the American drug market, substance use among service members, the changing cannabis market in Washington state, and more.

    Aug 29, 2019

  • East and Southeast Asia on a globe, photo by fpdress/Getty Images

    Newsletter

    Emerging Divergence: Drug Policy in Asia

    DPRC Quarterly, Issue 14, highlights research on direct dispensing of naloxone for opioid-related overdoses, conflicts over supervised drug consumption sites, tobacco and cannabis use among young adults, and more.

    May 15, 2019

  • Computer image of the hepatitis C virus,

    Newsletter

    How the Opioid Crisis Is Driving the Rise in Hepatitis C

    DPRC Quarterly, Issue 13, highlights the rise in Hepatitis C after the reformulation of Oxycontin, neonatal abstinence syndrome, adolescent marijuana use and legalization in Washington, and more.

    Feb 4, 2019

2018